FRONTEO,Inc. (2158)

Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndRetained earnings (Million JPY)YoY (%)
Mar 31, 2025-104-97.89%
Mar 31, 2024-4,960+134.32%
Mar 31, 2023-2,117+1409.75%
Mar 31, 2022-140-89.94%
Mar 31, 2021-1,394-20.48%
Mar 31, 2020-1,753+159.33%
Mar 31, 2019-676-7.17%
Mar 31, 2018-728-830.17%
Mar 31, 2017100-91.35%
Mar 31, 20161,153-18.87%
Mar 31, 20151,421
AI Chat